A Strategic Merger in Cancer Screening
A recent study relates future risk to current risk for advanced colorectal cancer. Dr Kerr suggests adding genetic testing to further improve diagnosis. (Source: Medscape Oncology)
Source: Medscape Oncology - October 18, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Colorectal Cancer Therapy Gets a Tune-up: ESMO 2017
Although not a year for big advances in colorectal cancer, exciting research with current standards was presented at ESMO 2017. (Source: Medscape Oncology)
Source: Medscape Oncology - October 2, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
New Data Provide Even More Support for Exercise During Cancer
The benefit of prescribing exercise for cancer-related fatigue is making more sense. (Source: Medscape Oncology)
Source: Medscape Oncology - August 31, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
PIVOT: Latest Data on Surveillance Versus Surgery for Prostate Cancer
Dr Gerald Chodak provides his perspective on updated data from a large trial of surveillance versus definitive treatment for prostate cancer, including strengths and weaknesses of the study. (Source: Medscape Oncology)
Source: Medscape Oncology - August 30, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Pembrolizumab, Larotrectinib Point to Future of Precision Medicine
With the examples of pembrolizumab and larotrectinib, Dr Markman discusses how precision cancer medicine will likely change the landscape of cancer therapy. (Source: Medscape Oncology)
Source: Medscape Oncology - August 8, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
New Data Address Critical Surgical Questions in Ovarian Cancer
At ASCO 2017, two trials tackled important surgical questions in ovarian cancer management, with the potential to eventually change practice, according to Dr Maurie Markman. (Source: Medscape Oncology)
Source: Medscape Oncology - August 4, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Cancer Drugs Not Working Hard Enough for the Money
Dr Peter Bach attributes the high cost of cancer drugs to the pharmaceutical industry ' s ' government-granted monopoly pricing power, ' saying that benefit to patients is not commensurate with price. (Source: Medscape Oncology)
Source: Medscape Oncology - July 10, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Potential ASCO Practice-Changers in HER2+ Breast Cancer
Oncologists will debate the APHINITY trial data for years to come, says Dr Kevin Kalinsky. (Source: Medscape Oncology)
Source: Medscape Oncology - July 7, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Cultivating Resiliency and Combating Burnout in Oncology
At ASCO 2017, experts provided practical tips for oncologists to develop resilience and prevent burnout in their professional lives. (Source: Medscape Oncology)
Source: Medscape Oncology - June 30, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
